Free Trial
OTCMKTS:CBBT

Cerebain Biotech (CBBT) Stock Price, News & Analysis

Cerebain Biotech logo
$0.0009 0.00 (0.00%)
As of 09/2/2021

About Cerebain Biotech Stock (OTCMKTS:CBBT)

Key Stats

Today's Range
$0.0008
$0.0010
50-Day Range
N/A
52-Week Range
$0.00
$0.47
Volume
2.04 million shs
Average Volume
11.21 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cerebain Biotech Corp. is a biomedical company, which engages in the creation and clinical development of a minimally invasive implantable device. It focuses on the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The company was founded on December 18, 2007 and is headquartered in Costa Mesa, CA.

Receive CBBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cerebain Biotech and its competitors with MarketBeat's FREE daily newsletter.

CBBT Stock News Headlines

ImClone Founder Waksal Forming New Biotech Venture
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.
Duopharma Biotech Bhd (DUOP)
Japan Biotech Startups Directory 2022
See More Headlines

CBBT Stock Analysis - Frequently Asked Questions

Cerebain Biotech's stock was trading at $0.0009 at the start of the year. Since then, CBBT shares have increased by 0.0% and is now trading at $0.0009.
View the best growth stocks for 2025 here
.

Shares of CBBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cerebain Biotech investors own include Bionano Genomics (BNGO), Aurora Cannabis (ACB), HUMBL (HMBL), Carnival Co. & (CCL), Canopy Growth (CGC), Enzolytics (ENZC) and SNDL (SNDL).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Wholesale
Current Symbol
OTCMKTS:CBBT
CIK
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:CBBT) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners